Management model to replace an original high cost drug for a generic formulation. Evaluation, monitoring and results.
High cost medicines and treatments are funded, in Uruguay, by one institution which manages a national insurance mandatory to all citizens. It provides universal coverage based on protocols built according to based-evidence medicine and to equality and sustainability criteria. Tacrolimus is financed for immunosuppressive treatment in solid organs transplantation. The original trademark was exclusively provided until May 2009, when a generic was introduced with a significant cost reduction.
Dra. Graciela Fernández, Dr. Abayubá Perna, Dr. Henry Albornoz, MSc. Gustavo Saona. Dra. Graciela Fernández, Dr. Abayubá Perna, Dr. Henry Albornoz, MSc. Gustavo Saona.
Tipo de publicación:
P. CIENTÍFICAS - Póster y Presentaciones